TY - CHAP PY - 2005 DA - 2005// BT - National diabetes fact sheet: United States, 2005: general information ID - ref1 ER - TY - JOUR PY - 2002 DA - 2002// TI - The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management-2002 update JO - Endocr Pract VL - 8 ID - ref2 ER - TY - JOUR PY - 2007 DA - 2007// TI - Standards of medical care in diabetes--2007 JO - Diabetes Care VL - 30 UR - https://doi.org/10.2337/dc07-S004 DO - 10.2337/dc07-S004 ID - ref3 ER - TY - JOUR AU - Stratton, I. M. AU - Adler, A. I. AU - Neil, H. A. AU - Matthews, D. R. AU - Manley, S. E. AU - Cull, C. A. AU - Hadden, D. AU - Turner, R. C. AU - Holman, R. R. PY - 2000 DA - 2000// TI - Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.405 DO - 10.1136/bmj.321.7258.405 ID - Stratton2000 ER - TY - JOUR PY - 1998 DA - 1998// TI - Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)07019-6 DO - 10.1016/S0140-6736(98)07019-6 ID - ref5 ER - TY - JOUR AU - Riddle, M. C. AU - Rosenstock, J. AU - Gerich, J. PY - 2003 DA - 2003// TI - The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.11.3080 DO - 10.2337/diacare.26.11.3080 ID - Riddle2003 ER - TY - JOUR AU - Saydah, S. H. AU - Fradkin, J. AU - Cowie, C. C. PY - 2004 DA - 2004// TI - Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JO - JAMA VL - 291 UR - https://doi.org/10.1001/jama.291.3.335 DO - 10.1001/jama.291.3.335 ID - Saydah2004 ER - TY - JOUR AU - Polonsky, W. H. AU - Jackson, R. A. PY - 2004 DA - 2004// TI - What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes JO - Clin Diabetes VL - 22 UR - https://doi.org/10.2337/diaclin.22.3.147 DO - 10.2337/diaclin.22.3.147 ID - Polonsky2004 ER - TY - STD TI - U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995, 44: 1249-1258. 10.2337/diabetes.44.11.1249. ID - ref9 ER - TY - JOUR AU - Turner, R. C. AU - Cull, C. A. AU - Frighi, V. AU - Holman, R. R. PY - 1999 DA - 1999// TI - Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JO - JAMA VL - 281 UR - https://doi.org/10.1001/jama.281.21.2005 DO - 10.1001/jama.281.21.2005 ID - Turner1999 ER - TY - JOUR AU - Wright, A. AU - Burden, A. C. F. AU - Paisey, R. B. AU - Cull, C. A. AU - Holman, R. R. PY - 2002 DA - 2002// TI - Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57) JO - Diabetes Care VL - 25 UR - https://doi.org/10.2337/diacare.25.2.330 DO - 10.2337/diacare.25.2.330 ID - Wright2002 ER - TY - CHAP PY - 2005 DA - 2005// BT - Implementation Conference for ACE Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position Statement, February 2, 2005 ID - ref12 ER - TY - CHAP AU - Leahy, J. L. ED - Leahy, J. L. ED - Cefalu, W. T. PY - 2002 DA - 2002// TI - Intensive insulin therapy in type 1 diabetes mellitus BT - Insulin Therapy PB - Marcel Dekker, Inc. CY - New York, NY UR - https://doi.org/10.1201/b14038-8 DO - 10.1201/b14038-8 ID - Leahy2002 ER - TY - JOUR AU - DeWitt, D. E. AU - Hirsch, I. B. PY - 2003 DA - 2003// TI - Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review JO - JAMA VL - 289 UR - https://doi.org/10.1001/jama.289.17.2254 DO - 10.1001/jama.289.17.2254 ID - DeWitt2003 ER - TY - JOUR AU - Gerich, J. E. PY - 2003 DA - 2003// TI - Clinical significance, pathogenesis, and management of postprandial hyperglycemia JO - Arch Intern Med VL - 163 UR - https://doi.org/10.1001/archinte.163.11.1306 DO - 10.1001/archinte.163.11.1306 ID - Gerich2003 ER - TY - JOUR AU - Monnier, L. PY - 2000 DA - 2000// TI - Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? JO - Eur J Clin Invest VL - 30 UR - https://doi.org/10.1046/j.1365-2362.30.s2.2.x DO - 10.1046/j.1365-2362.30.s2.2.x ID - Monnier2000 ER - TY - STD TI - Metabolic Pulse Web site. How to initiate basal-prandial insulin therapy: a reference guide for the primary care clinician. 2007, [http://www.metabolicpulse.org/IntActivities.do] UR - http://www.metabolicpulse.org/IntActivities.do ID - ref17 ER - TY - JOUR AU - Khaw, K. T. AU - Wareham, N. AU - Luben, R. AU - Bingham, S. AU - Oakes, S. AU - Welch, A. AU - Day, N. PY - 2001 DA - 2001// TI - Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) JO - BMJ VL - 322 UR - https://doi.org/10.1136/bmj.322.7277.15 DO - 10.1136/bmj.322.7277.15 ID - Khaw2001 ER - TY - JOUR AU - Khaw, K. T. AU - Wareham, N. AU - Bingham, S. AU - Luben, R. AU - Welch, A. AU - Day, N. PY - 2004 DA - 2004// TI - Association of hemoglobin A1C with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk JO - Ann Intern Med VL - 141 UR - https://doi.org/10.7326/0003-4819-141-6-200409210-00006 DO - 10.7326/0003-4819-141-6-200409210-00006 ID - Khaw2004 ER - TY - JOUR AU - Bonora, E. AU - Muggeo, M. PY - 2001 DA - 2001// TI - Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence JO - Diabetologia VL - 44 UR - https://doi.org/10.1007/s001250100020 DO - 10.1007/s001250100020 ID - Bonora2001 ER - TY - JOUR AU - Coutinho, M. AU - Gerstein, H. C. AU - Wang, Y. AU - Yusuf, S. PY - 1999 DA - 1999// TI - The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years JO - Diabetes Care VL - 22 UR - https://doi.org/10.2337/diacare.22.2.233 DO - 10.2337/diacare.22.2.233 ID - Coutinho1999 ER - TY - JOUR AU - Monnier, L. AU - Lapinski, H. AU - Colette, C. PY - 2003 DA - 2003// TI - Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.3.881 DO - 10.2337/diacare.26.3.881 ID - Monnier2003 ER - TY - JOUR AU - Etgen, G. J. AU - Oldham, B. A. AU - Johnson, W. T. AU - Broderick, C. L. AU - Montrose, C. R. AU - Brozinick, J. T. AU - Misener, E. A. AU - Bean, J. S. AU - Bensch, W. R. AU - Brooks, D. A. AU - Shuker, A. J. AU - Rito, C. J. AU - McCarthy, J. R. AU - Ardecky, R. J. AU - Tyhonas, J. S. AU - Dana, S. L. AU - Bilakovics, J. M. AU - Paterniti, J. R. AU - Ogilvie, K. M. AU - Liu, S. AU - Kauffman, R. F. PY - 2002 DA - 2002// TI - A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.4.1083 DO - 10.2337/diabetes.51.4.1083 ID - Etgen2002 ER - TY - CHAP AU - Hirsch, I. B. PY - 2005 DA - 2005// TI - Optimal initiation of insulin in type 2 diabetes BT - Medscape General Medicine ID - Hirsch2005 ER - TY - JOUR AU - Naik, R. G. AU - Palmer, J. P. PY - 2003 DA - 2003// TI - Latent autoimmune diabetes in adults (LADA) JO - Rev Endocr Metab Disord VL - 4 UR - https://doi.org/10.1023/A:1025148211587 DO - 10.1023/A:1025148211587 ID - Naik2003 ER - TY - JOUR AU - Pozzilli, P. AU - Di Mario, U. PY - 2001 DA - 2001// TI - Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention JO - Diabetes Care VL - 24 UR - https://doi.org/10.2337/diacare.24.8.1460 DO - 10.2337/diacare.24.8.1460 ID - Pozzilli2001 ER - TY - JOUR AU - Nabhan, F. AU - Emanuele, M. A. AU - Emanuele, N. PY - 2005 DA - 2005// TI - Latent autoimmune diabetes of adulthood: unique features that distinguish it from types 1 and 2 JO - Postgrad Med VL - 117 ID - Nabhan2005 ER - TY - JOUR AU - Cryer, P. E. AU - Davis, S. N. AU - Shamoon, H. PY - 2003 DA - 2003// TI - Hypoglycemia in diabetes JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.6.1902 DO - 10.2337/diacare.26.6.1902 ID - Cryer2003 ER - TY - JOUR AU - Hermansen, K. AU - Davies, M. AU - Derezinski, T. AU - Martinez Ravn, G. AU - Clauson, P. AU - Home, P. PY - 2006 DA - 2006// TI - A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/dc05-1365 DO - 10.2337/dc05-1365 ID - Hermansen2006 ER - TY - STD TI - Apidra [package insert]. 2005, Kansas City, Mo: Aventis Pharmaceuticals Inc, [http://products.sanofi-aventis.us/apidra/apidra.html] UR - http://products.sanofi-aventis.us/apidra/apidra.html ID - ref30 ER - TY - JOUR AU - Owens, D. R. AU - Zinman, B. AU - Bolli, G. B. PY - 2001 DA - 2001// TI - Insulins today and beyond JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)05842-1 DO - 10.1016/S0140-6736(01)05842-1 ID - Owens2001 ER - TY - STD TI - Exubera [package insert]. 2007, New York, NY: Pfizer Inc., [http://www.pfizer.com/pfizer/download/uspi_exubera.pdf] UR - http://www.pfizer.com/pfizer/download/uspi_exubera.pdf ID - ref32 ER - TY - STD TI - Byetta [package insert]. 2007, San Diego, Calif: Amylin Pharmaceuticals, Inc., [http://pi.lilly.com/us/byetta-pi.pdf] UR - http://pi.lilly.com/us/byetta-pi.pdf ID - ref33 ER - TY - JOUR AU - Edelman, S. V. PY - 2005 DA - 2005// TI - Incretins: what does the future hold? JO - Diabetes Technol Ther VL - 7 UR - https://doi.org/10.1089/dia.2005.7.809 DO - 10.1089/dia.2005.7.809 ID - Edelman2005 ER - TY - JOUR AU - Edelman, S. V. AU - Weyer, C. PY - 2002 DA - 2002// TI - Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone JO - Diabetes Technol Ther VL - 4 UR - https://doi.org/10.1089/15209150260007390 DO - 10.1089/15209150260007390 ID - Edelman2002 ER - TY - JOUR AU - Rašlová, K. AU - Bogoev, M. AU - Raz, I. AU - Leth, G. AU - Gall, M. A. AU - Hâncu, N. PY - 2004 DA - 2004// TI - Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes JO - Diabetes Res Clin Pract VL - 66 UR - https://doi.org/10.1016/j.diabres.2004.03.003 DO - 10.1016/j.diabres.2004.03.003 ID - Rašlová2004 ER - TY - JOUR AU - Davies, M. AU - Storms, F. AU - Shutler, S. AU - Bianchi-Biscay, M. AU - Gomis, R. PY - 2004 DA - 2004// TI - AT.LANTUS trial investigating treatment algorithms for insulin glargine (LANTUS): results of the type 2 study [abstract 1980-PO] JO - Diabetes VL - 53 ID - Davies2004 ER - TY - JOUR AU - Tanenberg, R. AU - Zisman, A. AU - Stewart, J. PY - 2006 DA - 2006// TI - Glycemia optimization treatment (GOT): glycemic control and rate of severe hypoglycemia for five different dosing algorithms of insulin glargine (GLAR) in patients with type 2 diabetes mellitus (T2DM) [abstract 567-P] JO - Diabetes VL - 55 (suppl 1) ID - Tanenberg2006 ER - TY - JOUR AU - Rohlfing, C. L. AU - Wiedmeyer, H. M. AU - Little, R. R. AU - England, J. D. AU - Tennill, A. AU - Goldstein, D. E. PY - 2002 DA - 2002// TI - Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial JO - Diabetes Care VL - 25 UR - https://doi.org/10.2337/diacare.25.2.275 DO - 10.2337/diacare.25.2.275 ID - Rohlfing2002 ER - TY - CHAP PY - 2006 DA - 2006// BT - New device approval: DexCom STS Continuous Glucose Monitoring System - P050012 ID - ref40 ER - TY - CHAP AU - Cefalu, W. T. ED - Leahy, J. L. ED - Cefalu, W. T. PY - 2002 DA - 2002// TI - Rationale for and strategies to achieve glycemic control BT - Insulin Therapy PB - Marcel Dekker Inc. CY - New York, NY ID - Cefalu2002 ER - TY - JOUR AU - Campbell, R. K. AU - White, J. R. PY - 2002 DA - 2002// TI - Insulin therapy in type 2 diabetes JO - J Am Pharm Assoc (Wash) VL - 42 UR - https://doi.org/10.1331/108658002763029580 DO - 10.1331/108658002763029580 ID - Campbell2002 ER - TY - CHAP AU - Ahmann, A. J. AU - Riddle, M. C. ED - Leahy, J. L. ED - Cefalu, W. T. PY - 2002 DA - 2002// TI - Insulin therapy in type 2 diabetes mellitus BT - Insulin Therapy PB - Marcel Dekker, Inc. CY - New York, NY UR - https://doi.org/10.1201/b14038-9 DO - 10.1201/b14038-9 ID - Ahmann2002 ER - TY - JOUR AU - Plank, J. AU - Bodenlenz, M. AU - Sinner, F. AU - Magnes, C. AU - Gorzer, E. AU - Regittnig, W. AU - Endahl, L. A. AU - Draeger, E. AU - Zdravkovic, M. AU - Pieber, T. R. PY - 2005 DA - 2005// TI - A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.5.1107 DO - 10.2337/diacare.28.5.1107 ID - Plank2005 ER -